Innoviva Inc banner

Intrinsic Value

Is INVA undervalued or overvalued?

See the intrinsic value estimate for Innoviva Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

INVA Intrinsic Value
LOCKED
Unlock
Today vs. history

INVA looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with INVA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor INVA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price $21.36
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to INVA

Fundamental Analysis

What Innoviva Does

Pharmaceuticals Health Care

Innoviva is a healthcare royalty company. Its main business is owning rights to receive payments on medicines developed and sold by other companies, especially inhaled treatments for lung diseases. Instead of running a big drug sales force, Innoviva sits further up the value chain and collects income when partner products sell well.

Headquarters
United States of America US
Employees
159
IPO date
Oct 5, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Innoviva Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

INVA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one INVA stock?

The intrinsic value for Innoviva Inc (INVA) under the Base Case is hidden USD.

Is INVA stock undervalued or overvalued?

Compared with the current market price of 21.355 USD, the stock appears hidden.

Back to Top